Home / Anti-infectives / Cefoperazone and Beta-Lactamase Inhibitor
ATC J01DD62 · Third-Generation Cephalosporins · updated 2 Nov 2026
Cefoperazone and Beta-Lactamase Inhibitor shortage
As of 2 Nov 2026, Cefoperazone and Beta-Lactamase Inhibitor has a reported shortage in 1 of the 16 countries we track (Japan), covering 2 products from 2 companies.
Is there a Cefoperazone and Beta-Lactamase Inhibitor shortage?
Yes. As of 2 Nov 2026, Cefoperazone and Beta-Lactamase Inhibitor is reported short in 1 of the 16 countries we track: Japan. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group J01DD · Third-Generation CephalosporinsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | ワイスタール配合静注用1g limited | Nipro | 14 Feb 2025 | not given | Increased demand |
| JP | セフォセフ静注用1g limited | Sawai | 10 Apr 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Cefoperazone and Beta-Lactamase Inhibitor shortage?
Yes. As of 2 Nov 2026, Cefoperazone and Beta-Lactamase Inhibitor is reported short in 1 of the 16 countries we track: Japan. No company has given a return date.
When will Cefoperazone and Beta-Lactamase Inhibitor be back in stock?
No return date has been given; Japan: no date given. These are company estimates reported to each authority.
Why is Cefoperazone and Beta-Lactamase Inhibitor in short supply?
The most common reason reported is: increased demand. Reasons by product are listed in the table below.
Which companies have Cefoperazone and Beta-Lactamase Inhibitor shortages?
Nipro, Sawai.